Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Machine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares RepurchasedShares Repurchased
Ratios

PharmaCyte Biotech (PMCB) Preferred Shares Repurchased (2020 - 2025)

PharmaCyte Biotech (PMCB) has disclosed Preferred Shares Repurchased for 3 consecutive years, with $3.7 million as the latest value for Q1 2025.

  • On a quarterly basis, Preferred Shares Repurchased fell 43.95% to $3.7 million in Q1 2025 year-over-year; TTM through Oct 2025 was $3.7 million, a 89.35% decrease, with the full-year FY2025 number at $22.5 million, up 39.15% from a year prior.
  • Preferred Shares Repurchased was $3.7 million for Q1 2025 at PharmaCyte Biotech, down from $9.3 million in the prior quarter.
  • In the past five years, Preferred Shares Repurchased ranged from a high of $9.5 million in Q2 2024 to a low of $3.7 million in Q1 2025.